Related Experiment Video
Updated: Aug 11, 2026
07:05
Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
Published on: May 17, 2015
Left ventricular mass increases during cardiac allograft vascular rejection
Journal of the American College of Cardiology
|March 15, 1995
Summary
Left ventricular mass significantly increases during vascular (humoral) cardiac allograft rejection but not during cellular rejection. This finding is crucial for understanding cardiac transplant outcomes and rejection management.
Area of Science:
- Cardiology
- Transplant Medicine
- Immunology
Background:
- Previous studies suggested left ventricular mass increases during cellular cardiac allograft rejection, but findings were controversial.
- Left ventricular mass changes during vascular (humoral) rejection were not previously evaluated.
Purpose of the Study:
- To evaluate left ventricular mass changes during cellular and vascular (humoral) cardiac allograft rejection.
- To clarify the impact of different rejection types on cardiac structure.
Main Methods:
- Retrospective review of 41 cardiac transplant recipients with allograft rejection.
- Analysis of endomyocardial biopsy results and echocardiograms.
- Left ventricular mass assessed by two-dimensional echocardiography.
Main Results:
- No significant changes in left ventricular mass during moderate/severe cellular rejection (grades III-IV).
- Marked increase in left ventricular mass (109 to 151 g) and wall thickness (1.3 to 1.6 cm) during vascular rejection.
- Vascular rejection associated with hemodynamic compromise (50% vs. 11% in cellular rejection).
Conclusions:
- Left ventricular mass increases during vascular (humoral) rejection episodes.
- No significant change in left ventricular mass occurs during cellular cardiac allograft rejection.
